Management & Regulatory

How Will Advancements Shape the Global C-Arms Market by 2024?
Management & Regulatory How Will Advancements Shape the Global C-Arms Market by 2024?

The global C-arms market is on the cusp of significant transformation, driven by technological advancements and evolving healthcare needs. Valued at $2.21 billion in 2023, the market is projected to reach $2.35 billion in 2024, continuing its growth trajectory. This article delves into the key

Engineering Microbes for a Sustainable and Renewable Bioeconomy
Management & Regulatory Engineering Microbes for a Sustainable and Renewable Bioeconomy

In the quest for a sustainable future, the bioeconomy emerges as a significant solution, aiming to replace finite petrochemical resources with renewable resources produced by living organisms. This vision is driven by the need to create a circular economy where products and materials are fully

Global Cell Culture Vessels Market to Reach $19.65B by 2033
Management & Regulatory Global Cell Culture Vessels Market to Reach $19.65B by 2033

The global cell culture vessels market is on a remarkable growth trajectory, projected to expand from an estimated USD 4.90 billion in 2023 to over USD 19.65 billion by 2033. This significant growth, at a robust CAGR of 14.9% from 2024 to 2033, underscores the critical role of cell culture

Gene Therapy Investment Falls Post-COVID, Showing Future Hope
Management & Regulatory Gene Therapy Investment Falls Post-COVID, Showing Future Hope

The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising

Widespread Layoffs in Biopharma: Economic and Strategic Challenges
Management & Regulatory Widespread Layoffs in Biopharma: Economic and Strategic Challenges

The biopharma industry, renowned for its rapid innovation and significant contributions to healthcare, currently faces a tumultuous period marked by widespread layoffs. From early 2023 through late 2024, numerous companies have announced substantial workforce reductions, which reflect a time of

South Korea's Pharma Transformation: CDMOs and Biosimilars Surge
Management & Regulatory South Korea's Pharma Transformation: CDMOs and Biosimilars Surge

South Korea's pharmaceutical and biotech industry is witnessing a fascinating shift as Contract Development and Manufacturing Organizations (CDMOs) and biosimilar developers are experiencing robust growth, while traditional pharmaceutical companies lag. At the forefront of this transition is

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later